Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fitness to drive with prolonged use of ICADTS class III medication
2013-004936-31Phase 4Completed
- Sponsor
- Ministry of Infrastructure and Water Management
- Start
- Jan 2014
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of alprazolam, amitriptyline, bromazepam, brotizolam, Chlordiazepoxide and 17 more in major depressive disorder (MDD), anxiety disorder and sleep disorder, sponsored by Ministry of Infrastructure and Water Management. Primary endpoint: Standard Deviation of Lateral Position (SDLP). Started Jan 2014; status: completed.
02
Drugs
alprazolamamitriptylinebromazepambrotizolamChlordiazepoxide
03
Conditions
major depressive disorder (MDD)anxiety disordersleep disorder
Beyond the preview
Go deeper on 2013-004936-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004936-31.